On the trail of those transgenic silkworms from KBLB Print E-mail
By M.E.Garza   
Wednesday, 08 September 2010 00:55

This story is of interest to our readers who picked up on our Watchlist Alert about transgenic silkworms from Kraig Biocraft Laboratories (OTC:KBLB). Turns out, they may be on to something afterall.

As we told our subscribers last week, Kraig Biocraft is pursuing the production of artificial spider silk through state-of-the-art genetic techniques designed to produce transgenic silkworms.  Impressively, this transgenic animal is expected to be capable of producing silk that contains spider silk protein – in short, they are capable of producing artificial spider silk.

The company confirmed yesterday that scientists working in collaboration with the Company have successfully created transgenic silkworms. The silkworms were successfully genetically engineered with targeted spider silk DNA sequences.





Transgenic silkworms could spin big profits

Kraig Biocraft Laboratories, Inc. Announces Press Conference Advisory Regarding Laboratory Developments

Kraig Biocraft Laboratories please visit the Company's web site: www.KraigLabs.com

To put this into perspective, investors need to understand that until now, very small quantities of artificial spider silk have ever been produced in laboratories. In fact, no one has ever been able to produce commercially viable quantities, but Kraig Biocraft seeks to do this via the creation of this new animal – a transgenic silkworm that contains specific DNA taken from spiders so that when the silkworm spins its cocoon the resulting silk is not ordinary silkworm silk, but is rather a combination of silkworm silk and spider silk – perhaps even pure spider silk.

"We are very excited to be able to announce our genetic engineering success," said CEO Kim K. Thompson. "The creation of these transgenics was greeted with much celebration among the scientists and in the corporate office. In my view our accomplishment establishes that we have been on the right track all along. This achievement is a landmark event for the Company. It clears a major hurdle in our path and puts us well ahead of our development schedule."

The Company plans to hold a press conference to discuss other significant laboratory developments and as is the case with these types of forward looking news events, it is likely that share prices will continue to increase in anticipation.

Share prices were as high as $0.04 during the down market session yesterday and have been rising nicely since our alert.

The news conference is expected to take place later this month and we are left to assume that the head researchers, Dr. Malcolm Fraser from the University of Notre Dame (a noted scientist who developed and perfected the most important insect related gene splicing technique), and Dr. Randy Lewis, of the University of Wyoming (one of the world’s foremost authorities on spider silk) will be present to announce more significant details.

 

Disclosure: No Positions




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter